A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
Most cancer patients do not respond to immune checkpoint therapies and the availability of predictive biomarkers is limited. Here the authors propose a signature enriched for genes of TREM2hi macrophages and γδ T cells to predict response to immunotherapy.
Guardado en:
Autores principales: | Donghai Xiong, Yian Wang, Ming You |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f272e035b0804ec2a83b8daf7b11d346 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reply to: “Inconsistent prediction capability of ImmuneCells.Sig across different RNA-seq datasets”
por: Donghai Xiong, et al.
Publicado: (2021) -
Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
por: Susu Zheng, et al.
Publicado: (2021) -
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer
por: Manuela Terranova-Barberio, et al.
Publicado: (2020) -
ASSOCIATION OF TREM-1 GENE POLYMORPHISMS WITH INFECTIVE ENDOCARDITIS
por: A. V. Ponasenko, et al.
Publicado: (2016) -
Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma
por: Shuo Hong, et al.
Publicado: (2021)